Halozyme Therapeutics
HALO
#1865
Rank
A$16.29 B
Marketcap
A$142.91
Share price
0.30%
Change (1 day)
31.50%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: A$16.29 Billion

As of November 2026 Halozyme Therapeutics has a market cap of A$16.29 Billion. This makes Halozyme Therapeutics the world's 1865th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026A$16.29 B34.75%
2025A$12.09 B22.82%
2024A$9.84 B37.38%
2023A$7.16 B-36.61%
2022A$11.30 B44.79%
2021A$7.80 B3.99%
2020A$7.50 B116.89%
2019A$3.46 B15.19%
2018A$3.00 B-18.64%
2017A$3.69 B108.15%
2016A$1.77 B-41.78%
2015A$3.04 B105.65%
2014A$1.48 B-22.98%
2013A$1.92 B164.48%
2012A$0.72 B-24.33%
2011A$0.96 B22.63%
2010A$0.78 B30.9%
2009A$0.59 B-7.33%
2008A$0.64 B2.04%
2007A$0.63 B-9.74%
2006A$0.70 B368.4%
2005A$0.14 B7.13%
2004A$0.13 B

End of Day market cap according to different sources

On Nov 17th, 2026 the market cap of Halozyme Therapeutics was reported to be:

A$16.24 Billion
by Nasdaq info icon info icon
A$16.24 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$994.82 B 6,005.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$240.71 B 1,377.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.878 T 11,429.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$169.51 B 940.41%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
A$19.87 B 21.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$1.94 B-88.04%๐Ÿ‡บ๐Ÿ‡ธ USA